TYROBP and neoplasm: The efficacy and safety profile was validated in a colorectal cancer (HCT116) xenograft model, where both CD3ζ and 4-1BB/CD3ζ CAR-T cells effectively reduced tumor burden, but only the DAP12 construct achieved complete eradication (104).